Skip to main content

Site notifications

(Approval lapsed) NeoMercazole carbimazole 5mg tablets bottle of 50 (France)

Section 19A approved medicine
(Approval lapsed) NeoMercazole carbimazole 5mg tablets bottle of 50 (France)
Section 19A approval holder
Amdipharm Mercury (Australia) Pty Ltd
Phone
1800 627 680
Approved until
Status
Expired
Medicines in short supply/unavailable
Carbimazole Neo-Mercazole 5mg tablets bottle of 100 - ARTG 194296
Indication(s)

Therapy of hyperthyroidism. Definitive therapy: induction of a permanent remission, in either primary or secondary thyrotoxicosis. Preparation for thyroidectomy. Before and after radioactive iodine treatment.

Additional information

NeoMercazole carbimazole 5mg tablets bottle of 50 (France) is registered in France and the packaging and product leaflet contains text in the French language. Pharmacists are instructed to direct consumers to disregard the patient leaflet for NeoMercazole carbimazole 5mg tablets bottle of 50 (France) contained within the pack and refer to the Australian Consumer Medicines Information available from: https://www.tga.gov.au .

Published

Help us improve the Therapeutic Goods Administration site